Literature DB >> 11315054

Efficient estimation of the distribution of quality-adjusted survival time.

H Zhao1, A A Tsiatis.   

Abstract

Quality of life is an important aspect in evaluation of clinical trials of chronic diseases, such as cancer and AIDS. Quality-adjusted survival analysis is a method that combines both the quantity and quality of a patient's life into one single measure. In this paper, we discuss the efficiency of weighted estimators for the distribution of quality-adjusted survival time. Using the general representation theorem for missing data processes, we are able to derive an estimator that is more efficient than the one proposed in Zhao and Tsiatis (1997, Biometrika 84, 339-348). Simulation experiments are conducted to assess the small sample properties of this estimator and to compare it with the semiparametric efficiency bound. The value of this estimator is demonstrated from an application of the method to a data set obtained from a breast cancer clinical trial.

Entities:  

Mesh:

Year:  1999        PMID: 11315054     DOI: 10.1111/j.0006-341x.1999.01101.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  13 in total

1.  Nonparametric Benefit-Risk Assessment Using Marker Process in the Presence of a Terminal Event.

Authors:  Yifei Sun; Chiung-Yu Huang; Mei-Cheng Wang
Journal:  J Am Stat Assoc       Date:  2017-04-12       Impact factor: 5.033

2.  Simultaneous modelling of survival and longitudinal data with an application to repeated quality of life measures.

Authors:  Donglin Zeng; Jianwen Cai
Journal:  Lifetime Data Anal       Date:  2005-06       Impact factor: 1.588

3.  A semi-Markov multistate model for estimation of the mean quality-adjusted survival for non-progressive processes.

Authors:  Gisela Tunes-da-Silva; Antonio C Pedroso-de-Lima; Pranab K Sen
Journal:  Lifetime Data Anal       Date:  2008-12-10       Impact factor: 1.588

4.  Predicting the restricted mean event time with the subject's baseline covariates in survival analysis.

Authors:  Lu Tian; Lihui Zhao; L J Wei
Journal:  Biostatistics       Date:  2013-11-29       Impact factor: 5.899

5.  Analysis of quality-of-life adjusted failure time data in the presence of competing, possibly informative, censoring mechanisms.

Authors:  Andrea Rotnitzky; Andrea Bergesio; Andres Farall
Journal:  Lifetime Data Anal       Date:  2008-06-25       Impact factor: 1.588

6.  Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.

Authors:  Xiaomin Lu; Anastasios A Tsiatis
Journal:  Lifetime Data Anal       Date:  2011-06-26       Impact factor: 1.588

7.  On optimal treatment regimes selection for mean survival time.

Authors:  Yuan Geng; Hao Helen Zhang; Wenbin Lu
Journal:  Stat Med       Date:  2014-12-16       Impact factor: 2.373

8.  Regression analysis of mean quality-adjusted survival time based on pseudo-observations.

Authors:  G Tunes-da-Silva; J P Klein
Journal:  Stat Med       Date:  2009-03-30       Impact factor: 2.373

9.  On the restricted mean survival time curve in survival analysis.

Authors:  Lihui Zhao; Brian Claggett; Lu Tian; Hajime Uno; Marc A Pfeffer; Scott D Solomon; Lorenzo Trippa; L J Wei
Journal:  Biometrics       Date:  2015-08-24       Impact factor: 2.571

10.  Optimization of individualized dynamic treatment regimes for recurrent diseases.

Authors:  Xuelin Huang; Jing Ning; Abdus S Wahed
Journal:  Stat Med       Date:  2014-02-09       Impact factor: 2.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.